Systematic review on the effectiveness of Brucella abortus S19 and RB51 vaccine strains in field studies.

Vaccine Pub Date : 2025-01-25 Epub Date: 2024-12-21 DOI:10.1016/j.vaccine.2024.126649
Maysa Serpa Gonçalves, Marina Martins de Oliveira, Rafaella Silva Andrade, Luciana Faria de Oliveira, Alessandro de Sá Guimarães, Jacques Godfroid, Andrey Pereira Lage, Elaine Maria Seles Dorneles
{"title":"Systematic review on the effectiveness of Brucella abortus S19 and RB51 vaccine strains in field studies.","authors":"Maysa Serpa Gonçalves, Marina Martins de Oliveira, Rafaella Silva Andrade, Luciana Faria de Oliveira, Alessandro de Sá Guimarães, Jacques Godfroid, Andrey Pereira Lage, Elaine Maria Seles Dorneles","doi":"10.1016/j.vaccine.2024.126649","DOIUrl":null,"url":null,"abstract":"<p><p>Brucella abortus S19 and RB51 are the most used vaccines to control bovine brucellosis worldwide; therefore, this study aimed to perform a systematic review on the effectiveness of these two vaccine strains in field studies. The literature review was conducted on April 3rd 2020 on six databases (CABI, Cochrane, PubMed, Scielo, Scopus and Web of Science) and included papers published between 1976 and 2016. The search strategy recovered a total of 5846 papers on databases and 6 papers were included due to specialists' suggestions. After selection, 17 papers were included, in which 33 trials were identified. Most trials [63.63 % (21/33)] used prevalence panel design (cross-sectional), while the others were cohort studies. S19 strain was used in most of the trials [75.76 % (25/33)], mainly by subcutaneous route [84.00 % (21/25)] and in adult cattle [76.00 % (19/25)]. RB51 strain was administrated only by the subcutaneous route and in both young and adult animals. For case definition, complement fixation [60.60 % (20/33)] and rivanol [30.30 % (10/33)] were the most used tests. Twenty of the 33 trials (60.61 %) showed significant effect of vaccination on brucellosis control, with lower incidence of infection in the vaccinated groups (in cohort trials) or reduced prevalence after vaccination (in prevalence panels); however, the great heterogeneity observed among the studies precluded a meta-analysis from the data extracted. In addition, most trials [57.57 % (19/33)] adopted other control measures (test-and-slaughter or isolation of positive animals from the herd) in association with vaccination, which harmed the better understand of the isolated effect of vaccination for brucellosis control in field in these studies. In conclusion, the result from this review suggests that both S19 and RB51 vaccine strains are effective in reducing brucellosis incidence in both calves and adults, as well as abortion rates, mainly when associated to other control policies.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":"45 ","pages":"126649"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.vaccine.2024.126649","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Brucella abortus S19 and RB51 are the most used vaccines to control bovine brucellosis worldwide; therefore, this study aimed to perform a systematic review on the effectiveness of these two vaccine strains in field studies. The literature review was conducted on April 3rd 2020 on six databases (CABI, Cochrane, PubMed, Scielo, Scopus and Web of Science) and included papers published between 1976 and 2016. The search strategy recovered a total of 5846 papers on databases and 6 papers were included due to specialists' suggestions. After selection, 17 papers were included, in which 33 trials were identified. Most trials [63.63 % (21/33)] used prevalence panel design (cross-sectional), while the others were cohort studies. S19 strain was used in most of the trials [75.76 % (25/33)], mainly by subcutaneous route [84.00 % (21/25)] and in adult cattle [76.00 % (19/25)]. RB51 strain was administrated only by the subcutaneous route and in both young and adult animals. For case definition, complement fixation [60.60 % (20/33)] and rivanol [30.30 % (10/33)] were the most used tests. Twenty of the 33 trials (60.61 %) showed significant effect of vaccination on brucellosis control, with lower incidence of infection in the vaccinated groups (in cohort trials) or reduced prevalence after vaccination (in prevalence panels); however, the great heterogeneity observed among the studies precluded a meta-analysis from the data extracted. In addition, most trials [57.57 % (19/33)] adopted other control measures (test-and-slaughter or isolation of positive animals from the herd) in association with vaccination, which harmed the better understand of the isolated effect of vaccination for brucellosis control in field in these studies. In conclusion, the result from this review suggests that both S19 and RB51 vaccine strains are effective in reducing brucellosis incidence in both calves and adults, as well as abortion rates, mainly when associated to other control policies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
实地研究中流产布鲁氏菌S19和RB51疫苗株有效性的系统评价。
流产布鲁氏菌S19和RB51是世界范围内控制牛布鲁氏菌病最常用的疫苗;因此,本研究旨在对这两种疫苗株在实地研究中的有效性进行系统评价。文献综述于2020年4月3日在六个数据库(CABI、Cochrane、PubMed、Scielo、Scopus和Web of Science)上进行,包括1976年至2016年间发表的论文。检索策略在数据库中共检索到5846篇论文,根据专家建议,有6篇论文被纳入。经筛选,纳入文献17篇,共鉴定试验33项。大多数试验[63.63%(21/33)]采用患病率面板设计(横断面),其他试验采用队列研究。S19菌株在大多数试验中使用[75.76%(25/33)],主要通过皮下途径使用[84.00 %(21/25)],在成年牛中使用[76.00 %(19/25)]。RB51菌株仅通过皮下给药,在幼龄和成年动物中均有效。对于病例定义,补体固定[60.60%(20/33)]和利凡诺[30.30%(10/33)]是最常用的检测方法。33项试验中有20项(60.61%)显示疫苗接种对布鲁氏菌病控制有显著影响,接种疫苗组(队列试验)的感染发生率较低,接种疫苗后的患病率降低(流行病学调查);然而,在这些研究中观察到的巨大异质性妨碍了对提取的数据进行荟萃分析。此外,大多数试验[57.57%(19/33)]在接种疫苗的同时采取了其他控制措施(试验屠宰或从畜群中隔离阳性动物),这不利于更好地了解这些研究中接种疫苗对布鲁氏菌病现场控制的孤立效果。总之,本综述的结果表明,S19和RB51疫苗株都能有效降低犊牛和成牛的布鲁氏菌病发病率,以及流产率,主要是在与其他控制政策相结合的情况下。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine. Vaccine safety surveillance in South Africa through COVID-19: A journey to systems strengthening. Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer. Predictors of HPV vaccination coverage among adolescents in Tennessee during the COVID-19 pandemic: A cross-sectional study. Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1